-
- Lorry G. Rubin
- Division of Pediatric Infectious Diseases, Steven and Alexandra Cohen Children's Medical Center of New York of the North Shore-LIJ Health System, New Hyde Park
-
- Myron J. Levin
- Section of Pediatric Infectious Diseases, University of Colorado Denver Anschutz Medical Campus, Aurora
-
- Per Ljungman
- Department of Hematology, Karolinska University Hospital
-
- E. Graham Davies
- Department of Immunology, Great Ormond Street Hospital & Institute of Child Health, London, United Kingdom
-
- Robin Avery
- Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, Maryland
-
- Marcie Tomblyn
- Department of Blood and Marrow Transplant, H. Lee Moffitt Cancer Center and Research Institute, University of South Florida, Tampa
-
- Athos Bousvaros
- Department of Gastroenterology and Nutrition, Children's Hospital Boston, Massachusetts
-
- Shireesha Dhanireddy
- Department of Allergy and Infectious Diseases, University of Washington, Seattle
-
- Lillian Sung
- Division of Hematology-Oncology, Hospital for Sick Children, Toronto, Ontario, Canada
-
- Harry Keyserling
- Division of Pediatric Infectious Diseases, Emory University of School of Medicine, Atlanta, Georgia
-
- Insoo Kang
- Section of Rheumatology, Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut
説明
<jats:title>Abstract</jats:title><jats:p>An international panel of experts prepared an evidenced-based guideline for vaccination of immunocompromised adults and children. These guidelines are intended for use by primary care and subspecialty providers who care for immunocompromised patients. Evidence was often limited. Areas that warrant future investigation are highlighted.</jats:p>
収録刊行物
-
- Clinical Infectious Diseases
-
Clinical Infectious Diseases 58 (3), e44-e100, 2013-12-04
Oxford University Press (OUP)
